Masimo (MASI) Competitors $148.13 +0.84 (+0.57%) Closing price 04:00 PM EasternExtended Trading$148.07 -0.06 (-0.04%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MASI vs. AMN, VEEV, DXCM, STE, PODD, HOLX, BAX, GMED, TFX, and ITGRShould you be buying Masimo stock or one of its competitors? The main competitors of Masimo include AMN Healthcare Services (AMN), Veeva Systems (VEEV), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Teleflex (TFX), and Integer (ITGR). These companies are all part of the "medical" sector. Masimo vs. Its Competitors AMN Healthcare Services Veeva Systems DexCom STERIS Insulet Hologic Baxter International Globus Medical Teleflex Integer AMN Healthcare Services (NYSE:AMN) and Masimo (NASDAQ:MASI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership, media sentiment and dividends. Does the media favor AMN or MASI? In the previous week, Masimo had 6 more articles in the media than AMN Healthcare Services. MarketBeat recorded 7 mentions for Masimo and 1 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 1.82 beat Masimo's score of 0.46 indicating that AMN Healthcare Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Masimo 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is AMN or MASI more profitable? AMN Healthcare Services has a net margin of -10.75% compared to Masimo's net margin of -24.85%. Masimo's return on equity of 26.54% beat AMN Healthcare Services' return on equity.Company Net Margins Return on Equity Return on Assets AMN Healthcare Services-10.75% 11.09% 3.34% Masimo -24.85%26.54%11.49% Do analysts recommend AMN or MASI? AMN Healthcare Services currently has a consensus target price of $23.25, indicating a potential upside of 17.19%. Masimo has a consensus target price of $194.60, indicating a potential upside of 31.37%. Given Masimo's stronger consensus rating and higher probable upside, analysts plainly believe Masimo is more favorable than AMN Healthcare Services.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AMN Healthcare Services 2 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.13Masimo 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75 Do insiders & institutionals have more ownership in AMN or MASI? 99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 86.0% of Masimo shares are held by institutional investors. 0.9% of AMN Healthcare Services shares are held by insiders. Comparatively, 9.7% of Masimo shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better valuation & earnings, AMN or MASI? AMN Healthcare Services has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAMN Healthcare Services$2.77B0.27-$146.98M-$7.77-2.55Masimo$2.15B3.74-$304.90M-$8.52-17.39 Which has more risk and volatility, AMN or MASI? AMN Healthcare Services has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500. Comparatively, Masimo has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. SummaryMasimo beats AMN Healthcare Services on 10 of the 17 factors compared between the two stocks. Get Masimo News Delivered to You Automatically Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASI vs. The Competition Export to ExcelMetricMasimoMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.05B$7.00B$6.10B$10.62BDividend YieldN/A1.10%5.64%4.70%P/E Ratio-17.3927.4585.6627.14Price / Sales3.74194.41527.83206.38Price / Cash23.0622.4126.3031.12Price / Book7.605.2812.906.66Net Income-$304.90M$178.04M$3.30B$275.95M7 Day Performance3.63%3.44%4.87%3.38%1 Month Performance0.64%10.03%8.18%10.84%1 Year Performance6.70%29.21%75.72%33.58% Masimo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASIMasimo4.394 of 5 stars$148.13+0.6%$194.60+31.4%+6.1%$8.05B$2.15B-17.395,600AMNAMN Healthcare Services4.394 of 5 stars$18.51-1.9%$23.25+25.6%-46.6%$723.18M$2.98B-2.382,968Positive NewsVEEVVeeva Systems3.9437 of 5 stars$293.15+1.0%$301.48+2.8%+44.9%$47.58B$2.75B58.057,291Positive NewsAnalyst DowngradeInsider TradeDXCMDexCom4.9405 of 5 stars$66.46-1.0%$99.11+49.1%-1.6%$26.31B$4.03B46.1510,300STESTERIS4.8953 of 5 stars$245.37-1.5%$273.50+11.5%+5.0%$24.53B$5.46B37.5817,787Positive NewsPODDInsulet4.7497 of 5 stars$310.62-2.3%$345.76+11.3%+34.4%$22.38B$2.07B94.413,900Analyst ForecastHOLXHologic4.7985 of 5 stars$67.15-0.1%$79.38+18.2%-15.0%$14.95B$4.03B27.867,063BAXBaxter International4.8057 of 5 stars$22.36+1.7%$30.11+34.7%-34.2%$11.29B$10.64B-74.5238,000GMEDGlobus Medical4.9254 of 5 stars$56.49+1.4%$87.64+55.1%-14.3%$7.52B$2.52B21.735,300Positive NewsTFXTeleflex4.612 of 5 stars$120.65+0.6%$141.57+17.3%-45.2%$5.30B$3.05B28.3914,100ITGRInteger4.062 of 5 stars$101.06-0.4%$140.25+38.8%-18.5%$3.56B$1.72B44.5211,000 Related Companies and Tools Related Companies AMN Healthcare Services Alternatives Veeva Systems Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Hologic Alternatives Baxter International Alternatives Globus Medical Alternatives Teleflex Alternatives Integer Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MASI) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredThe Dollar’s Crashing—What Are You Doing About It?The U.S. dollar is down 10.8%—its steepest drop since 1973. As global confidence in the dollar fades, centr...Lear Capital | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Masimo Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Masimo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
